CH622262A5 - - Google Patents

Download PDF

Info

Publication number
CH622262A5
CH622262A5 CH1630975A CH1630975A CH622262A5 CH 622262 A5 CH622262 A5 CH 622262A5 CH 1630975 A CH1630975 A CH 1630975A CH 1630975 A CH1630975 A CH 1630975A CH 622262 A5 CH622262 A5 CH 622262A5
Authority
CH
Switzerland
Prior art keywords
triazol
cephem
carboxylic acid
amino
ylthiomethyl
Prior art date
Application number
CH1630975A
Other languages
German (de)
English (en)
Inventor
David Alan Berges
Original Assignee
Smithkline Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Corp filed Critical Smithkline Corp
Publication of CH622262A5 publication Critical patent/CH622262A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
CH1630975A 1974-12-27 1975-12-16 CH622262A5 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/536,759 US3989694A (en) 1974-12-27 1974-12-27 7-Acyl-3-(substituted triazolyl thiomethyl)cephalosporins

Publications (1)

Publication Number Publication Date
CH622262A5 true CH622262A5 (fi) 1981-03-31

Family

ID=24139827

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1630975A CH622262A5 (fi) 1974-12-27 1975-12-16

Country Status (14)

Country Link
US (2) US3989694A (fi)
JP (1) JPS5188989A (fi)
AU (1) AU8789275A (fi)
BE (1) BE837071A (fi)
CA (1) CA1085822A (fi)
CH (1) CH622262A5 (fi)
DE (1) DE2558024A1 (fi)
ES (2) ES442100A1 (fi)
FR (2) FR2313068A1 (fi)
GB (2) GB1539518A (fi)
IE (1) IE43127B1 (fi)
IT (1) IT1051939B (fi)
NL (1) NL7513872A (fi)
ZA (1) ZA756192B (fi)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS612674B2 (fi) * 1974-06-20 1986-01-27 Meiji Seika Co
US4172196A (en) * 1974-09-03 1979-10-23 Bristol-Myers Company Certain 7-α-substituted-α-hydroxyacetamido-3-(1-carboxymethyltetrazol-5-yl-thiomethyl)-3-cephem-4-carboxylic acids
US4182863A (en) * 1974-09-03 1980-01-08 Bristol-Myers Company 7-Amino-3-(1-carboxymethyltetrazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid
US3989694A (en) * 1974-12-27 1976-11-02 Smithkline Corporation 7-Acyl-3-(substituted triazolyl thiomethyl)cephalosporins
IL49183A0 (en) * 1975-03-27 1976-05-31 Pfizer Novel cephalosporin derivatives,their preparation and pharmaceutical compositions containing them
US4183925A (en) * 1975-03-27 1980-01-15 Pfizer Inc. 7-Aminophenylacetamido-Δ3 -cephem antibacterial agents and method of use
US4220644A (en) * 1976-05-03 1980-09-02 Smithkline Corporation 7-Acylamino-3-(substituted tetrazolyl thiomethyl) cephalosporins
US4082912A (en) * 1976-06-30 1978-04-04 Bristol-Myers Company Certain 7-acylamido-3-(2-carboxyalkyl-2,3-dihydro-s-triazolo[4,3-b]pyridazin-3-on-6-ylmethyl)-3-cephem-4-carboxylic acids their salts and easily hydrolyzed esters
JPS5321191A (en) * 1976-08-10 1978-02-27 Shionogi & Co Ltd 7-arylmalonamidocephem derivatives
US4057631A (en) * 1976-09-02 1977-11-08 Smithkline Corporation 7-(α-Substituted phenylacetamido)-3-(1-carboxymethylthioethyltetrazolyl-5-thiomethyl)-3-cephem-4-carboxylic acids
US4083975A (en) * 1976-09-24 1978-04-11 Smithkline Corporation 7-Acylamino-3-(3-sulfomethyl-1,2,4-triazol-5-ylthiomethyl)-3-cephem-4-carboxylic acids
US4174324A (en) * 1977-06-30 1979-11-13 Smithkline Corporation 3-(Carboxymethyl)thio-1H-1,2,4-triazol-5-thione
US4117124A (en) * 1977-06-30 1978-09-26 Smithkline Corporation 7-Acylamino-3-[[3-(carboxymethyl)thio-1H-1,2,4-triazol-5-yl]thiomethyl]-3-cephem-4-carboxylic acids
US4197240A (en) * 1977-12-23 1980-04-08 Yeda Research And Development Co. Ltd. Penicillin derivatives
US4229575A (en) * 1978-02-27 1980-10-21 Richardson-Merrell Inc. 7-(2,3-Dihydrobenzo-5-furanyl)-acetamido cephalosporin derivatives
US4219648A (en) * 1978-03-06 1980-08-26 Richardson-Merrell Inc. 7-[[Amino(1,3-dihydrobenzo[c]thienyl)acetyl]amino]cephalosporin derivatives
US4749522A (en) * 1985-10-31 1988-06-07 Angio-Medical Corporation Supercritical fluid extraction of animal derived materials
PT87616B (pt) 1987-06-24 1992-09-30 Smithkline Beecham Corp Processo de preparacao de antagonistas do leucotrieno e de composicoes farmaceuticas

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL173169C (nl) 1969-10-27 1983-12-16 Fujisawa Pharmaceutical Co Werkwijze voor het bereiden van een farmaceutisch preparaat met antibacteriele werking en werkwijze voor het bereiden van het daarvoor benodigde cephalosporinederivaat.
US3759904A (en) * 1971-07-29 1973-09-18 Bristol Myers Co Ds and salts thereof 3 - (s-(1,2,3-triazole-5-yl)thiomethyl)-3 - cephem - 4-carboxylic aci7-(d-(alpha-amino-alpha-phenyl-, 2-thienyl- and 3-thienylacetamido))-
US3796801A (en) * 1971-11-04 1974-03-12 Smithkline Corp Method of combating enterobacter infections
BE793037A (fr) * 1971-12-23 1973-06-20 Fujisawa Pharmaceutical Co Procede de preparation de derives d'acide 7-acylamino-3-substitue-3-cephem-4-carboxylique et nouveaux produits ainsi obtenus
US3813388A (en) * 1972-01-31 1974-05-28 L Crast 7-(d-(alpha-amino-alpha-phenyl-,2-thienyl-and 3-thienyl-acetamido))-3-(s-(2-methyl-1,2,3-triazole-4-yl)thiomethyl)-3-cephem-4-carboxylic acids
US4007173A (en) 1973-05-07 1977-02-08 Smithkline Corporation α-amino-α-(ureidophenyl)acetamidocephalosporins
JPS5653557B2 (fi) * 1973-10-15 1981-12-19
GB1476981A (en) * 1974-06-05 1977-06-16 Bristol Myers Co Substituted penicillanic acids
US3989694A (en) * 1974-12-27 1976-11-02 Smithkline Corporation 7-Acyl-3-(substituted triazolyl thiomethyl)cephalosporins

Also Published As

Publication number Publication date
NL7513872A (nl) 1976-06-29
IE43127L (en) 1976-06-27
GB1539518A (en) 1979-01-31
BE837071A (fr) 1976-06-24
US3989694A (en) 1976-11-02
US4142046A (en) 1979-02-27
CA1085822A (en) 1980-09-16
ES442100A1 (es) 1977-07-01
JPS5188989A (fi) 1976-08-04
ES456340A1 (es) 1978-01-16
FR2303807B1 (fi) 1980-10-24
AU8789275A (en) 1977-06-30
IE43127B1 (en) 1980-12-31
FR2313068B1 (fi) 1979-09-28
FR2303807A1 (fr) 1976-10-08
IT1051939B (it) 1981-05-20
DE2558024A1 (de) 1976-07-08
GB1539517A (en) 1979-01-31
FR2313068A1 (fr) 1976-12-31
ZA756192B (en) 1976-09-29

Similar Documents

Publication Publication Date Title
DE2727753C2 (fi)
DE2519400C3 (de) Penicillinverbindungen, Verfahren zur Herstellung derselben und Mittel mit einem Gehalt derselben
CH622262A5 (fi)
DE1795292B2 (de) Cephalosporinderivate und Verfahren zu deren Herstellung
US4154830A (en) Unsaturated derivatives of 7-acylamido-3-cephem-4-carboxylic acid
DE2539664C2 (fi)
GB1573004A (en) Cephalosporin compounds
CH622523A5 (fi)
US4061748A (en) 7-(α-(4-Hydroxy-1,5-naphthyridine-3-carbonamido)-α-phenylacetamido) cephalosporin derivatives
US4231928A (en) Antibacterial agents
US4220644A (en) 7-Acylamino-3-(substituted tetrazolyl thiomethyl) cephalosporins
DE2521063A1 (de) Phenylacetamidocephalosporin- derivate
US4117126A (en) 7-(α-(4-Hydroxy-1,5-naphthyridine-3-carbonamido)-α-phenylacetamido) cephalosporin derivatives
DE2527291C2 (fi)
DE2700271A1 (de) Thienopyridinderivate
DE3041160A1 (de) 1-oxadethia-cephalosporin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende antibakterielle mittel
US4117125A (en) 7-Acylamino-3-[1-[2-(carboxymethylamino]ethyl) tetrazol-5-ylthiomethyl]-3-cephem-4-carboxylic acids
DE2330307A1 (de) Cephalosporinverbindungen, ihre salze, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2710490A1 (de) 7-acylamino-3-(5-sulfoalkyl-1,3,4- oxadiazol-2-ylthiomethyl)-3-cephem-4- carbonsaeuren, ihre salze, verfahren zu ihrer herstellung, zwischenprodukte und arzneimittel
US4079134A (en) 7-Acylamino-3-(5-sulfomethyl-1,3,4-thiadiazol-2-ylthiomethyl)-3-cephem-4-carboxylic acids
US4064242A (en) 7-Acylamino-3-[1-(2,3-dihydroxypropyl)tetrazole-5-ylthiomethyl]-3-cephem-4-carboxylic acids
CS195680B2 (en) Process for preparing derivatives of 7-/substituted phenylglycinamido/-3-substituted-3-cephem-4-carboxylic acid
KR20000076288A (ko) 항균성 치환 7-아실아미노-3-(메틸히드라조노)메틸-세팔로스포린 및 중간체
US4088761A (en) 3-[(1,3-Dithiin-5-yl)-acetamido]-cephalosporins and antibacterial compositions containing them
GB1604740A (en) 7-isothiazolylthioacetamido-7-methoxycephalosporanic acid derivatives

Legal Events

Date Code Title Description
PL Patent ceased